大黄鱼弧菌病流行特征与防控研究概述

    Overview on epidemic characteristics and prevention-control research of large yellow croaker (Larimichthys crocea) Vibriosis

    • 摘要:
      背景 弧菌病持续流行严重制约大黄鱼养殖产业的可持续发展。当前,病原演替呈现由单一病原感染向以哈维氏弧菌为主导、多菌协同感染转变的复杂态势;抗菌药物不合理使用所引发的耐药性扩散,进一步加速优势病原演替并加剧防控困境。
      目的 本文聚焦大黄鱼弧菌病病原演替与耐药性的生态效应,解析优势病原种群更替的驱动因素、耐药基因在养殖环境中的扩散途径及其生态后果,探讨二者对疾病流行格局与防控模式的重塑作用。
      进展 在流行特征方面,哈维氏弧菌凭借较强的环境适应、生物被膜形成及胁迫耐受等特性,逐步成为优势病原。在耐药演化方面,抗菌药物选择压力下,质粒、整合子、转座子等可移动遗传元件介导耐药基因水平转移,重塑弧菌群落结构,并形成推动优势菌扩张的正反馈循环。在致病机制方面,弧菌毒力因子及胞外产物可诱导宿主炎症失衡和免疫病理损伤,促进组织损伤和疾病恶化。针对上述挑战,防控研究正由单一药物依赖转向多层次综合干预:在精准检测层面,病原与耐药性快速检测及药敏监测有助于及时鉴定优势病原和耐药表型,使抗菌药物选择由经验判断转向精准施药;在免疫调控层面,经浸泡或口服途径递送的黏膜疫苗及免疫增强剂可增强宿主黏膜和系统性抗感染能力;在生态调控层面,益生菌和微生态调控可通过竞争营养与黏附位点、产生抑菌代谢物等抑制弧菌定植与生物被膜形成,配合养殖密度和水质管理,从环境源头降低病原丰度并减少抗菌药物依赖。基于病原精准检测、黏膜免疫调控及养殖生态优化的绿色防控技术,有望突破传统药物依赖的局限。
      展望 未来大黄鱼弧菌病防控重心需从“杀灭病原”转向“生态调控”,通过发展黏膜疫苗、抗病育种和微生态调控,构建病原-免疫-环境协同的精准管理体系,推动产业绿色可持续发展。

       

      Abstract: Background: Vibriosis remains persistently prevalent and severely restricts the sustainable development of the large yellow croaker (Larimichthys crocea) aquaculture industry. Currently, pathogen succession shows a complex trend shifting from single-pathogen infections to polymicrobial synergistic infections dominated by Vibrio harveyi. The spread of antimicrobial resistance caused by inappropriate use of antimicrobial agents has further accelerated dominant pathogen succession and exacerbated prevention and control challenges.Objective: This review focuses on the ecological effects of pathogen succession and antimicrobial resistance in large yellow croaker vibriosis. It elucidates the drivers of succession of dominant pathogen populations, the dissemination pathways and ecological consequences of antimicrobial resistance genes in aquaculture environments, and discusses how these two processes reshape disease epidemiological patterns and prevention and control strategies.Progress: In terms of epidemiological characteristics, V. harveyi has gradually become the dominant pathogen owing to its strong environmental adaptability, biofilm formation capacity, and stress tolerance. In terms of resistance evolution, under the selective pressure of antimicrobial agents, mobile genetic elements such as plasmids, integrons, and transposons mediate the horizontal transfer of resistance genes, reshape Vibrio community structure, and form a positive feedback loop that promotes the expansion of dominant strains. In terms of pathogenic mechanisms, Vibrio virulence factors and extracellular products can induce inflammatory imbalance and immunopathological damage in the host, thereby promoting tissue damage and disease exacerbation. In response to these challenges, prevention and control research is shifting from sole reliance on antimicrobials to multi-level integrated interventions. At the precision detection level, rapid detection of pathogens and antimicrobial resistance, together with antimicrobial susceptibility monitoring, facilitates the timely identification of dominant pathogens and resistance phenotypes, shifting antimicrobial selection from empirical judgment to precision antimicrobial therapy. At the immune regulation level, mucosal vaccines and immunostimulants delivered via immersion or oral routes can enhance host mucosal and systemic anti-infection capacity. At the ecological regulation level, probiotics and microecological regulation can inhibit Vibrio colonization and biofilm formation by competing for nutrients and adhesion sites and producing antimicrobial metabolites; combined with stocking density and water quality management, these measures reduce pathogen abundance at the environmental source and decrease reliance on antimicrobials. Green prevention and control technologies based on precision pathogen detection, mucosal immune regulation, and aquaculture ecological optimization are expected to overcome the limitations of traditional antimicrobial dependence.Outlook: In the future, the focus of large yellow croaker vibriosis prevention and control should shift from “pathogen elimination” to “ecological regulation.” By developing mucosal vaccines, disease-resistant breeding, and microecological regulation, a precision management system coordinating pathogen, immunity, and environment should be established to promote the green and sustainable development of the industry.

       

    /

    返回文章
    返回